- Home
- JEF vs PCVX Comparison
JEF vs PCVX Comparison
Compare JEF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEF
- PCVX
- Stock Information
- Founded
- JEF 1968
- PCVX 2013
- Country
- JEF United States
- PCVX United States
- Employees
- JEF N/A
- PCVX N/A
- Industry
- JEF Investment Bankers/Brokers/Service
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- JEF Finance
- PCVX Health Care
- Exchange
- JEF Nasdaq
- PCVX Nasdaq
- Market Cap
- JEF 11.8B
- PCVX 11.5B
- IPO Year
- JEF N/A
- PCVX 2020
- Fundamental
- Price
- JEF $65.62
- PCVX $79.74
- Analyst Decision
- JEF Strong Buy
- PCVX Strong Buy
- Analyst Count
- JEF 3
- PCVX 8
- Target Price
- JEF $81.67
- PCVX $127.71
- AVG Volume (30 Days)
- JEF 1.3M
- PCVX 881.2K
- Earning Date
- JEF 03-26-2025
- PCVX 02-25-2025
- Dividend Yield
- JEF 2.14%
- PCVX N/A
- EPS Growth
- JEF 171.82
- PCVX N/A
- EPS
- JEF 2.99
- PCVX N/A
- Revenue
- JEF $7,010,603,000.00
- PCVX N/A
- Revenue This Year
- JEF $17.38
- PCVX N/A
- Revenue Next Year
- JEF $12.04
- PCVX N/A
- P/E Ratio
- JEF $21.87
- PCVX N/A
- Revenue Growth
- JEF 49.15
- PCVX N/A
- 52 Week Low
- JEF $40.72
- PCVX $58.10
- 52 Week High
- JEF $82.68
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- JEF 27.48
- PCVX 36.96
- Support Level
- JEF $70.19
- PCVX $82.03
- Resistance Level
- JEF $72.20
- PCVX $84.10
- Average True Range (ATR)
- JEF 1.96
- PCVX 3.12
- MACD
- JEF -0.80
- PCVX -0.70
- Stochastic Oscillator
- JEF 5.35
- PCVX 1.88
About JEF Jefferies Financial Group Inc.
Jefferies Financial Group Inc is a diversified financial services company. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.